BACKGROUND: To evaluate clinical features and prognostic factors of cerebral infarctions in adults with community-acquired bacterial meningitis. METHOD: An observational cross-sectional study, including 696 patients of whom 174 had cerebral infarction, from a prospective nationwide cohort of community-acquired bacterial meningitis (period, 1998-2002), confirmed by culture of cerebral spinal fluid (CSF) in patients aged over 16 years. Two investigators independently determined the presence of infarction. RESULT: Cerebral infarction occurred in 174 episodes (25%), with a high inter-rater agreement for determining the presence of cerebral infarction (kappa 0.95). Cerebral infarctions occurred in 128 of 352 patients (36%) with pneumococcal meningitis, in 22 of 257 (9%) with meningococcal meningitis and in 24 of 87 patients (28%) with meningitis caused by other bacteria. Patients with infarctions were older (P < 0.001) and often presented with predisposing conditions, such as otitis and/or sinusitis (P = 0.001) or an immunocompromised state (P = 0.003) compared to those without infarction. Patients with infarctions presented with lower scores on the Glasgow Coma Scale (P < 0.001), lower CSF white cell counts (P = 0.001), and higher serum erythrocyte sedimentation rate (ESR) (P < 0.001). Unfavorable outcome occurred in 108 (62%) patients with infarctions. In a multivariate analysis, infarction was related with unfavorable outcome (odds ratio 3.37; 95% confidence interval 2.19-5.21; P < 0.001). We identified lower CSF white cell counts and high ESR to be independent risk factors for cerebral infarction. CONCLUSION: Cerebral infarction is a common and severe complication in adults with community-acquired bacterial meningitis. Preventing cerebral infarctions will be important in reducing the high morbidity and mortality rate in adults with community-acquired bacterial meningitis.
BACKGROUND: To evaluate clinical features and prognostic factors of cerebral infarctions in adults with community-acquired bacterial meningitis. METHOD: An observational cross-sectional study, including 696 patients of whom 174 had cerebral infarction, from a prospective nationwide cohort of community-acquired bacterial meningitis (period, 1998-2002), confirmed by culture of cerebral spinal fluid (CSF) in patients aged over 16 years. Two investigators independently determined the presence of infarction. RESULT: Cerebral infarction occurred in 174 episodes (25%), with a high inter-rater agreement for determining the presence of cerebral infarction (kappa 0.95). Cerebral infarctions occurred in 128 of 352 patients (36%) with pneumococcal meningitis, in 22 of 257 (9%) with meningococcal meningitis and in 24 of 87 patients (28%) with meningitis caused by other bacteria. Patients with infarctions were older (P < 0.001) and often presented with predisposing conditions, such as otitis and/or sinusitis (P = 0.001) or an immunocompromised state (P = 0.003) compared to those without infarction. Patients with infarctions presented with lower scores on the Glasgow Coma Scale (P < 0.001), lower CSF white cell counts (P = 0.001), and higher serum erythrocyte sedimentation rate (ESR) (P < 0.001). Unfavorable outcome occurred in 108 (62%) patients with infarctions. In a multivariate analysis, infarction was related with unfavorable outcome (odds ratio 3.37; 95% confidence interval 2.19-5.21; P < 0.001). We identified lower CSF white cell counts and high ESR to be independent risk factors for cerebral infarction. CONCLUSION: Cerebral infarction is a common and severe complication in adults with community-acquired bacterial meningitis. Preventing cerebral infarctions will be important in reducing the high morbidity and mortality rate in adults with community-acquired bacterial meningitis.
Authors: Martijn Weisfelt; Rogier M Determann; Jan de Gans; Arie van der Ende; Marcel Levi; Diederik van de Beek; Marcus J Schultz Journal: J Infect Date: 2007-01-04 Impact factor: 6.072
Authors: Martijn Weisfelt; Diederik van de Beek; Lodewijk Spanjaard; Johannes B Reitsma; Jan de Gans Journal: Lancet Neurol Date: 2006-02 Impact factor: 44.182
Authors: Diederik van de Beek; Jan de Gans; Lodewijk Spanjaard; Martijn Weisfelt; Johannes B Reitsma; Marinus Vermeulen Journal: N Engl J Med Date: 2004-10-28 Impact factor: 91.245
Authors: Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210
Authors: Barry B Mook-Kanamori; Daan Fritz; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240
Authors: Mercedes Valls Serón; Bart Ferwerda; JooYeon Engelen-Lee; Madelijn Geldhoff; Valery Jaspers; Aeilko H Zwinderman; Michael W Tanck; Frank Baas; Arie van der Ende; Matthijs C Brouwer; Diederik van de Beek Journal: Acta Neuropathol Commun Date: 2016-05-18 Impact factor: 7.801
Authors: Bart Ferwerda; Mercedes Valls Serón; Aldo Jongejan; Aeilko H Zwinderman; Madelijn Geldhoff; Arie van der Ende; Frank Baas; Matthijs C Brouwer; Diederik van de Beek Journal: EBioMedicine Date: 2016-07-12 Impact factor: 8.143